Interventional Glaucoma

Mt. Sinai to introduce the miDOC system at the ASCRS annual meeting

A trio of ASCRS presentations collectively offer insight to surgeons, suggesting that glaucoma drops harm meibomian glands, while combining cataract surgery with MIGS can boost long-term IOP control.

Oluwatosin U. Smith, MD, provides an overview of angle-based techniques, cyclodialysis cleft repair, and minimally invasive approaches to glaucoma surgical complications.

Key regulatory filings, phase 3 readouts, and trial enrollments to watch through June 30.

The prospective, multicenter study enrolled 318 patients across 20 US sites.

Ian Pitha, MD, PhD, argues that leveraging large-scale utilization data to identify the highest-impact medications could help the field get ahead of supply disruptions before they reach patients.

See which ophthalmology surgery centers earn US News’ 2026 high-performing badge, where they cluster, and why complication rates drop 40%.

The 3rd Winterthur Ophthalmology Symposium in Winterthur, Switzerland, on 12–13 March 2026 will feature plenary talks, hands-on workshops, satellite sessions, poster presentations, and a gala honoring the Otto Haab Medal.

Pitha discusses how ophthalmic drug shortages — more frequent and longer-lasting than the national average — are threatening adherence to glaucoma therapy.

Marta Pazos, MD, PhD, on how OCT and emerging AI can help spot preperimetric glaucoma years before vision loss while avoiding false positives from myopia and disc anatomy.

Experts share practical and research-based advancements, offering actionable strategies in diagnosis, treatment, and early detection.

The BIM-IOL System consists of 2 non-bioerodible drug pads attached to the optic-haptic junction of a monofocal intraocular lens (IOL), which is implanted as part of routine cataract surgery.

Paula Anne Newman-Casey, MD, MS, explains the multifactorial needs and her decades-long research that resulted in the SEE program for glaucoma patients.

The 6-month Support, Educate, Empower (SEE) program was associated with a 20% improvement in glaucoma treatment adherence and reduced distress among adult patients.

Take a look at some, but certainly not all, that you may have missed from this year’s EnVision Summit.

Inder Paul Singh, MD, spoke alongside Mary Qiu, MD, and Danica J. Marrelli, OD, FAAO, AAODip, in a CE Spotlight Symposium at the conference.

Zarmeena Vendal, MD, discussed the intersections between cataract surgery and glaucoma.

Nicole Bajic, MD, outlines key takeaways from her case study involving Descemet membrane detachment occurring in the setting of focal canaloplasty using the Streamline Surgical System.

Pathik P. Amin, OD, FAAO, details his segment of an educational track session on glaucoma at this year's conference.

Most patients do well on topical therapy, but innovation in IOP-lowering drops remains essential.

Proactive strategies enhance comfort, adherence and long-term glaucoma control

EnVision Summit insights spotlight complex glaucoma cases, MIGS pitfalls, and personalized surgery choices—preview the issues driving 2026 debates in Puerto Rico.

NYU Grossman’s Preeya Mehta, MD, and Jonathan S. Williams, MD, sit down with Mount Sinai’s Louis R. Pasquale, MD, to discuss long-term safety and efficacy data from a PreserFlo microshunt trial and the role of microshunts in glaucoma surgery.